PureTech Health (PRTC) Debt to Equity (2020 - 2023)

PureTech Health (PRTC) has 4 years of Debt to Equity data on file, last reported at $0.03 in Q4 2023.

• Debt to Equity for Q4 2023 came in at $0.03, up 250.02% year-over-year; the trailing twelve-month figure through Dec 2023 was $0.03 (up 250.02% YoY), and the FY2023 annual result was $0.03, up 250.02% from the prior year.
• Debt to Equity climbed to $0.03 in Q4 2023 per PRTC's latest filing, from $0.01 in the prior quarter.
• Over five years, Debt to Equity peaked at $0.03 in Q4 2023 and troughed at $0.01 in Q4 2022.
• A 4-year average of $0.02 and a median of $0.02 in 2021 frame the typical range for Debt to Equity.
• The sharpest annual moves came in 2022 and 2023: Debt to Equity plunged 62.67% in 2022, then soared 250.02% in 2023.
• A 4-year view of Debt to Equity shows it stood at $0.02 in 2020, then increased by 15.13% to $0.03 in 2021, then tumbled by 62.67% to $0.01 in 2022, then soared by 250.02% to $0.03 in 2023.
• Business Quant data shows PRTC's Debt to Equity at $0.03 in Q4 2023, $0.01 in Q4 2022, and $0.03 in Q4 2021.